Eli Lilly shares jump on compelling next-gen weight-loss data
Shares of Eli Lilly (NYSE:LLY) rose 4% on Monday after the company unveiled highly anticipated clinical data for its next-generation obesity treatment, retatrutide.
Brie Carter
TV Presenter & Finance EditorTV presenter and finance editor at Grafa, with a Master’s in Commerce from UWA and diverse industry experience in finance, insurance, and media.
Contact
Contact editorial teamArticles by Brie Carter
Johnson & Johnson to acquire Firefly Bio for $1 billion
Johnson & Johnson (NYSE:JNJ) announced today that it has entered into a definitive agreement to acquire Firefly Bio for $1 billion in cash.
RedHill Biopharma initiates enforcement of $10.9M judgment against Kukbo in Korea
RedHill Biopharma (NASDAQ:RDHL) announced on June 8, 2026, that it has officially commenced recognition and enforcement proceedings in South Korea to collect on a final judgment awarded by the New York Supreme Court against Kukbo.
Technology
AstroNova reports profit growth and strong order momentum in fiscal Q1 2027
AstroNova (NASDAQ:ALOT), a global leader in specialized print technology solutions, reported financial results for its fiscal 2027 first quarter ended April 30, 2026.
Retail
Duluth narrows losses as margin expansion offsets sales decline
Duluth Holdings (NASDAQ:DLTH) reported financial results for the first quarter of fiscal 2026, ended May 3, 2026, highlighting significant progress in operational efficiency despite a challenging retail environment.
Japan yen warning revives crypto crash fears
The return of the USD/JPY exchange rate above the 160 level has revived concerns that Japan could once again become a catalyst for turbulence across global financial markets, including cryptocurrencies.
Oil and Gas
Oil prices surge as Middle East tensions escalate, Strait of Hormuz risks mount
Global oil markets faced heightened volatility on Monday as investors reacted to an escalation in regional conflict.
Cryptocurrency
DWF Labs warns of corporate crypto crash
DWF Labs founder Andrei Grachev has warned that the growing concentration of Bitcoin and Ethereum in the hands of publicly listed companies could create the conditions for the largest crash in crypto market history.
Artiva Biotherapeutics reports positive AlloNK data and FDA RMAT designation
Artiva Biotherapeutics (NASDAQ:ARTV) has shared encouraging clinical findings for its lead therapeutic candidate, AlloNK® (AB-101), during the European Alliance of Associations for Rheumatology (EULAR) 2026 congress.
CLARITY Act odds fall as Senate clock ticks
The CLARITY Act's chances of becoming law in 2026 have fallen to 60% from 75%, according to Galaxy Digital, as lawmakers face a narrowing window to advance landmark crypto legislation before the Senate's August recess.